Accelerated onset of heart failure in mice during pressure overload with chronically decreased SERCA2 calcium pump activity.

We recently developed a mouse model with a single functional allele of Serca2 (Serca2+/-) that shows impaired cardiac contractility and relaxation without overt heart disease. The goal of this study was to test the hypothesis that chronic reduction in sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA)2 levels in combination with an increased hemodynamic load will result in an accelerated pathway to heart failure. Age-matched wild-type and Serca2+/- mice were subjected to 10 wk of pressure overload via transverse aortic coarctation surgery. Cardiac hypertrophy and heart failure were assessed by echocardiography, gravimetry/histology, hemodynamics, and Western blotting analyses. Our results showed that approximately 64% of coarcted Serca2+/- mice were in heart failure compared with 0% of coarcted wild-type mice (P < 0.05). Overall, morbidity and mortality were greatly increased in Serca2+/- mice under pressure overload. Echocardiography assessment revealed a significant increase in left ventricular (LV) mass, and LV hypertrophy in coarcted Serca2+/- mice converted from a concentric to an eccentric pattern, similar to that seen in human heart failure. Coarcted Serca2+/- mice had decreased contractile/systolic and relaxation/diastolic performance and/or function compared with coarcted wild-type mice (P < 0.05), despite a similar duration and degree of pressure overload. SERCA2a protein levels were significantly reduced (>50%) in coarcted Serca2+/- mice compared with noncoarcted and coarcted wild-type mice. Our findings suggest that reduction in SERCA2 levels in combination with an increased hemodynamic load results in an accelerated pathway to heart failure.

[1]  Masahiko Hoshijima,et al.  Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery , 2002, Nature Medicine.

[2]  S. Vatner,et al.  The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. , 2002, The Journal of clinical investigation.

[3]  T. Doetschman,et al.  TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II , 2002 .

[4]  B. Hoit,et al.  Hypertrophy and functional alterations in hyperdynamic phospholamban-knockout mouse hearts under chronic aortic stenosis. , 2002, Cardiovascular research.

[5]  U. Schmidt,et al.  Improvement in Survival and Cardiac Metabolism After Gene Transfer of Sarcoplasmic Reticulum Ca2+-ATPase in a Rat Model of Heart Failure , 2001, Circulation.

[6]  W. Manning,et al.  Transgenic Expression of Sarcoplasmic Reticulum Ca2+ ATPase Modifies the Transition From Hypertrophy to Early Heart Failure , 2001, Circulation research.

[7]  E. Marbán,et al.  Sarcoplasmic Reticulum Ca2+ ATPase (SERCA) 1a Structurally Substitutes for SERCA2a in the Cardiac Sarcoplasmic Reticulum and Increases Cardiac Ca2+ Handling Capacity , 2001, Circulation research.

[8]  R. Hajjar,et al.  Overwhelming evidence of the beneficial effects of SERCA gene transfer in heart failure. , 2001, Circulation research.

[9]  H. Knot,et al.  Impaired sarcoplasmic reticulum function leads to contractile dysfunction and cardiac hypertrophy. , 2001, American journal of physiology. Heart and circulatory physiology.

[10]  L. Leinwand,et al.  Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. , 2001, The Journal of clinical investigation.

[11]  H. Crijns,et al.  Early expression of natriuretic peptides and SERCA in mild heart failure: association with severity of the disease. , 2001, International journal of cardiology.

[12]  G. Dorn,et al.  Interactions Between Phospholamban and &bgr;-Adrenergic Drive May Lead to Cardiomyopathy and Early Mortality , 2001, Circulation.

[13]  D L Kirkpatrick,et al.  Disruption of a Single Copy of the SERCA2 Gene Results in Altered Ca2+ Homeostasis and Cardiomyocyte Function* , 2000, The Journal of Biological Chemistry.

[14]  J. Guerrero,et al.  Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Martone,et al.  Chronic Phospholamban–Sarcoplasmic Reticulum Calcium ATPase Interaction Is the Critical Calcium Cycling Defect in Dilated Cardiomyopathy , 1999, Cell.

[16]  S. Pawlowski,et al.  Fibroblast growth factor-2 mediates pressure-induced hypertrophic response. , 1999, The Journal of clinical investigation.

[17]  T. Doetschman,et al.  Impaired Cardiac Performance in Heterozygous Mice with a Null Mutation in the Sarco(endo)plasmic Reticulum Ca2+-ATPase Isoform 2 (SERCA2) Gene* , 1999, The Journal of Biological Chemistry.

[18]  R. Walsh,et al.  Enhanced myocardial contractility and increased Ca2+ transport function in transgenic hearts expressing the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+-ATPase. , 1998, Circulation research.

[19]  J. Lorenz,et al.  End-systolic stress-velocity and pressure-dimension relationships by transthoracic echocardiography in mice. , 1998, American journal of physiology. Heart and circulatory physiology.

[20]  G. Hasenfuss,et al.  Alterations of calcium-regulatory proteins in heart failure. , 1998, Cardiovascular research.

[21]  H. Rockman,et al.  Overexpression of the rat sarcoplasmic reticulum Ca2+ ATPase gene in the heart of transgenic mice accelerates calcium transients and cardiac relaxation. , 1997, The Journal of clinical investigation.

[22]  D. Bers,et al.  Downregulation of sarcoplasmic reticulum Ca(2+)-ATPase during progression of left ventricular hypertrophy. , 1997, The American journal of physiology.

[23]  J. Lorenz,et al.  Measurement of intraventricular pressure and cardiac performance in the intact closed-chest anesthetized mouse. , 1997, The American journal of physiology.

[24]  F. Müller,et al.  Messenger RNA expression and immunological quantification of phospholamban and SR-Ca(2+)-ATPase in failing and nonfailing human hearts. , 1996, Cardiovascular research.

[25]  R. Walsh,et al.  Differential changes in cardiac phospholamban and sarcoplasmic reticular Ca(2+)-ATPase protein levels. Effects on Ca2+ transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure. , 1995, Circulation research.

[26]  HanjörgJust,et al.  Alterations in Intracellular Calcium Handling Associated With the Inverse Force-Frequency Relation in Human Dilated Cardiomyopathy , 1995 .

[27]  H. Drexler,et al.  Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. , 1994, Circulation research.

[28]  M. Arai,et al.  Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. , 1994, Circulation research.

[29]  B. Lorell,et al.  Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. , 1993, Circulation research.

[30]  N. Alpert,et al.  Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. , 1993, Circulation research.

[31]  A. Lompré,et al.  Function of the sarcoplasmic reticulum and expression of its Ca2(+)-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. , 1990, Circulation research.

[32]  N. Alpert,et al.  Regulation of myocardial Ca2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[34]  R. Schwinger,et al.  Effect of inotropic interventions on the force-frequency relation in the human heart , 1998, Basic Research in Cardiology.

[35]  N. Alpert,et al.  Sarcoplasmic reticulum gene expression in pressure overload-induced cardiac hypertrophy in rabbit. , 1995, The American journal of physiology.

[36]  K. Boheler,et al.  Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure. , 1990, The Journal of clinical investigation.